Introduction
Nosocomial infections (NIs) represent a serious public health concern worldwide (1), and, especially, in developing countries where, due to financial constraints, it is difficult to control (2, 3) . Increased prevalence of NIs in some cases leads to patient's arbitrary use of drugs, causing serious health hazards as well as other problems such as drug resistance and death in patients (4) . Worldwide, about 8.7% of hospitalized patients are at risk of exposure to NIs which considered as hospital-acquired infections and can complicate certain conditions such as cancer, organ transplant, and surgery, and also increasing mortality rate. As such, NIs generate a high societal burden, taking http://mjiri.iums.ac.ir Med J Islam Repub Iran. 2018(11 June); 32:48.
2 into account the costs for treatment, the increased length of hospital stay and the related mental and emotional stress (5) .
Due to the wide variation of health-care systems in different countries, numerous reports have reported varying nosocomial infection rates (6, 7) . The World Health Organization (WHO) carried out an epidemiological study conducted in 14 countries worldwide and found that the overall prevalence of NIs was 8.7% (ranging from 5.0% in North America and in Europe to 40 .0% in Asia, Latin America, and Sub-Saharan Africa) (7) . The knowledge of the epidemiology of NIs is crucial in establishing programs for controlling this acquired infection in hospitals, implementing effective and reliable plans (8) .
Iran represents one of the developing countries, which faces with the issue of NIs imposing a high economic onus, in terms of high costs annually for the Ministry of Health (MoH) and private hospital managers. Several studies have been performed in different parts of the country related to the epidemiology of nosocomial infections. These studies can be valuable for healthcare workers and managers in developing an effective control program. This study aimed to review and assess the prevalence of NIs in Iran using a meta-analytic approach.
Methods

Literature search
The results and their analysis in this study were reported according to the PRISMA guidelines (Appendix 1) (9). Embase, PubMed/MEDLINE via Ovid, Web of Science, Scopus and Google Scholar as well as national Iranian databases, including SID, Magiran, and Irandoc, with medical subject headings (MeSH) terms and a proper use of keywords. The search strategy was as follows: (Nosocomial Infections OR Hospital Infections OR Healthcare Associated Infections OR Cross Infections) AND Iran. Articles written in Farsi and English were searched and a time filter (between January 2000 and December 2017) applied. Reference lists of articles as well as national and international conferences related to the topic were also searched.
Inclusion and exclusion criteria
Inclusion criteria were: 1) population-based observational studies reporting the prevalence of NIs, 2) crosssectional, retrospective and case-control studies, and 3) pertinent studies with clear and detailed data. Case reports, case series, letters to editor, editorials, commentaries, reviews and clinical trials as well as studies not calculating the prevalence of NIs , as well as studies not calculating the prevalence of NIs were excluded.
Data extraction
From included papers, two authors independently extracted following data: first author, year of publication, sample size, number of positive cases detected, age, region, the geography of the study, study design, and prevalence rate. Disagreement between them was solved through discussion or including a third person as a judge.
Quality of studies
To check the methodological quality of included studies, the strengthening the reporting of observational studies in epidemiology (STROBE) checklist was used (10) , categorizing the studies into three groups of high, medium and low quality.
Statistical analysis
To determine the pooled prevalence, the stochastic DerSimonian-Laird model was used, computing the effect size with its 95% confidence interval (CI) and pictorially representing it with a Forest plot. To examine the heterogeneity among studies, the I 2 test were conducted (11) . To further investigate the source of heterogeneity, metaregression analyses stratified by publication year, sample size and duration of hospitalization in the hospital were carried out. The sensitivity analysis was performed to ensure the stability and robustness of results. Subgroup analyses were performed based on study quality, geographic areas, sample size, year of publication, type of infection, and hospital wards. The cumulative meta-analysis was performed based on year of publication. Egger's test for publication bias was carried out (12) . All analyses were performed using the commercial software Comprehensive Meta-Analysis Ver.2 (Biostat, NJ, USA). All figures with p<0.05 were considered statistically significant.
Results
Selected studies
Finally, after an initial search, removing duplicates and checking the title and abstract of studies, 52 studies were selected based on inclusion and exclusion criteria . Fig. 1 shows the process of finding and selecting studies.
The total sample size consisted of 8,989,980 subjects. Table 1 shows the main characteristics of the included studies.
The overall prevalence of nosocomial infections in Iran
Based on the random-effects model, the overall prevalence of NIs in Iran was 4.5% [95% CI: 3.5 to 5.7] with a high, statistically significant heterogeneity (I 2 =99.82). Fig.  2 shows the overall prevalence.
Sensitivity analysis
A sensitivity analysis was performed to ensure the stability results. After removing each study, results did not change. Appendix 2 shows the sensitivity analysis.
Cumulative meta-analysis
A cumulative meta-analysis of the included studies was performed based on year of publication and the results did not change. Appendix 3 shows the cumulative metaanalysis. Table 2 shows the results of the different sub-group analyses according to the quality of studies, geographic regions, sample size, year of publication, type of infection, and hospital wards. Table 3 shows the results of the meta-regression analysis.
Sub-group analysis
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Meta-regression
Publication bias
Egger's test was carried out to assess publication bias (Fig. 3 ). An evidence of publication bias was found (p=0.00) Fig. 1 . Flowchart of the present systematic review and meta-analysis 4
Discussion
This study was a comprehensive study on the prevalence of NIs in Iran using a systematic review and metaanalytic approach. The prevalence of NIs in Iran was found as 4.5% (95% CI: 3.5-5.7). Hospital infection rates range between 3.5% and 12% in developed countries and between 5.7% and 19.1% in developing countries (7), calling for the urgent need of better allocating resources and implementing a program for controlling infections (65) . Differences in NIs rates among countries may not 
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only reflect a socio-economical feature of each country but also depend on criteria and diagnostic tests used to detect infections, as well as on the different reporting systems and their quality (66) . We found that bloodstream infections, surgical site infections, and pneumonia were the most common NIs observed (67) . Hospital-acquired pneumonia is directly related to air conditioning systems. In many developing countries due to lack of proper facilities, the installed ventilation systems may increase pneumonia rate (68) . Studies have shown that surgical infection rates vary between 10% and 20%, and are mainly due to Staphylococcus aureus (69) . In cases of complications, wound healing is delayed, the possibility of further surgery increases, and patients have to be treated with antibiotics. This increases the length of hospital stay and the health-related expenditure (70) .
In our study, most infections occurred in the surgical ward. A study carried out in America reported a 2-5% rate (71) , while a meta-analysis of surgical infection rate estimated a pooled prevalence of 3.7% (72) . Surgical infections are particularly challenging (73) . Identifying patients who are prone to such infections could minimize the incidence of nosocomial infections and reduce their burden in terms of deaths (71) . Further, our study computed a higher effect-size of infections caused by Gram-positive bacteria. A study computed a prevalence of these infections of about 5% (3). Similar results were found by other scholars (74, 75) . In the ICU, a significant amount of infections are due to Gram-positive bacteria, and this trend is increasing (76) .
In the present study, a high rate of infections caused by Klebsiella pneumoniae (urinary tract , respiratory tract , and bloodstream infections) was found (77) . This is particularly alarming in that the organism can become resistant to Carbapenem, which leads to increased use of Colistin, absorbing higher costs (78) . Moreover, our study showed a strong correlation between length of stay in the hospital and hospital infections rate, in agreement with other studies (79) (80) (81) . Based on geographical regions of Iran, the south of the country reported the highest incidence of NIs (8.8%), due to weather conditions, being warm and dry, with high air temperature and humidity. The prevalence of NIs can vary according to the specific month of the year (82) .
Meta-regression analysis based on year of publication showed a significant decreasing trend over the years, which may be due to the recent implementation of health promotion programs (83) . Despite some strengths (including the systematic approach, and the robustness of findings as proven by the meta-regressions and by the subgroup, cumulative, and sensitivity analyses), some limitations of this study should be properly recognized. First, the heterogeneity was significantly high. This could reflect methodological differences among studies. Moreover, insufficient information was available to stratify the prevalence by gender. Further, in some provinces of Iran, epidemiological studies related to the prevalence of NIs were missing and, therefore, urgently needed.
Conclusion
The prevalence of NIs in Iran was determined as 4.5%. Preventing and reducing hospital infections can significantly impact on reducing mortality and health-related costs tor. Implementing ad hoc programs, such as training healthcare staff in hospital, can play an important role in reducing spread of infections. The use of appropriate and advanced features for secure hospital environment is a major contribution to the decrease of NIs. Health policymakers in Iran can help reduce hospital infections by implementing appropriate policies, such as educational programs and improving the quality of surveillance system. 
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